Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566

Genes, brain, and behavior

Volumn 16, Issue 7, 2017, Pages 739-

  Deacon, R M J ^a,b,c   Hurley, M J ^c,d   Rebolledo, C M ^e   Snape, M ^f   Altimiras, F J ^a,g   Farias L ^a,g   Pino, M ^a   Biekofsky, R ^b   Glass, L ^h   Cogram, P ^a,c,e  

^a Fraunhofer Chile Research Foundation   (Chile)

^b National Scientific and Technical Research Council ^*  (United Kingdom)

^c FAVALORO UNIVERSITY   (Argentina)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CHILE   (Chile)

^f AMO Pharmaceuticals Ltd   (United Kingdom)

^g UNIVERSIDAD ADOLFO IBÁÑEZ   (Chile)

^h MD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85018890081     PISSN: None     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12373     Document Type: TB

References (0)